Gene · 5891
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses. | Aging Dis | 2024 | 37450931 | PubTator, text mining | PubMed |
| Decoding the mechanism of earthworm extract against wounds: an integrated metabolomics and network pharmacology study. | Mol Divers | 2024 | 36705857 | PubTator, text mining | PubMed |
| [Exploring the mechanisms of Jujing pill on varicocele-associated male infertility via network pharmacology and molecular docking technology]. | Zhonghua Nan Ke Xue | 2023 | 38619514 | PubTator, text mining | PubMed |
| Identification and Validation of PTGS2 Gene as an Oxidative Stress-Related Biomarker for Arteriovenous Fistula Failure. | Antioxidants (Basel) | 2023 | 38275625 | PubTator, text mining | PubMed |
| Pan-cancer analysis of SERPINE family genes as biomarkers of cancer prognosis and response to therapy. | Front Mol Biosci | 2023 | 38274096 | PubTator, text mining | PubMed |
| New sights of immunometabolism and agent progress in colitis associated colorectal cancer. | Front Pharmacol | 2023 | 38273841 | PubTator, text mining | PubMed |
| The Hepatic Antisteatosis Effect of Xanthohumol in High-Fat Diet-Fed Rats Entails Activation of AMPK as a Possible Protective Mechanism. | Foods | 2023 | 38231665 | PubTator, text mining | PubMed |
| Comprehensive exploration of JQ1 and GSK2801 targets in breast cancer using network pharmacology and molecular modeling approaches. | Comput Struct Biotechnol J | 2023 | 38213901 | PubTator, text mining | PubMed |
| Exploring the potential mechanism of Simiao Yongan decoction in the treatment of diabetic peripheral vascular disease based on network pharmacology and molecular docking technology. | Medicine (Baltimore) | 2023 | 38206683 | PubTator, text mining | PubMed |
| The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives. | Int J Mol Sci | 2023 | 38203718 | PubTator, text mining | PubMed |
Assessment of Hematological Profiles and Prognostic Role of Hemogram-Derived Novel Markers for Diabetes Mellitus and Its Complications Among Type 2 Diabetes Mellitus Adult Patients Attending Bishoftu General Hospital, Central, Ethiopia: A Comparative Cross-Sectional Study. | J Blood Med | 2023 | 38164459 | PubTator, text mining | PubMed |
Network Pharmacology Combined with Molecular Docking, Molecular Dynamics, and In Vitro Experimental Validation Reveals the Therapeutic Potential of Thymus vulgaris L. Essential Oil (Thyme Oil) against Human Breast Cancer. | ACS Omega | 2023 | 38144096 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Effects of Glycemic Carbohydrates on the Neurocognitive Functions Based on Gut Microenvironment Regulation and Glycemic Fluctuation Control. | Nutrients | 2023 | 38140339 | PubTator, text mining | PubMed |
| The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies. | Int J Mol Sci | 2023 | 38139154 | PubTator, text mining | PubMed |
| CD200/CD200R: Bidirectional Role in Cancer Progression and Immunotherapy. | Biomedicines | 2023 | 38137547 | PubTator, text mining | PubMed |
| A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. | Biomedicines | 2023 | 38137450 | PubTator, text mining | PubMed |
| Anti-Osteoarthritis Mechanism of the Nrf2 Signaling Pathway. | Biomedicines | 2023 | 38137397 | PubTator, text mining | PubMed |
| Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease. | Cancers (Basel) | 2023 | 38136277 | PubTator, text mining | PubMed |
| Key Therapeutic Targets to Treat Hyperglycemia-Induced Atherosclerosis Analyzed Using a Petri Net-Based Model. | Metabolites | 2023 | 38132873 | PubTator, text mining | PubMed |
| Network pharmacology analysis and experimental validation of Anemarrhenae Rhizoma in treating Alzheimer's disease. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 38105702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5891/papers?page=11